Moderna and Merck scored a big win for their cancer vaccine on Wednesday. But analysts say it's too early to call it a home run. The post Moderna's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real